Skip to Content


In the US, Aztreonam (aztreonam systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Bacterial Infection, Bone infection, Cystic Fibrosis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Skin and Structure Infection, Skin or Soft Tissue Infection and Urinary Tract Infection.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Monobactam

Chemical Name

(Z)-2-[[[(2-amino-4-tiazolyl)[[(2S,3S)-2-metyl-4-oxo-1-sulfo-3-azetidinyl]carbamoyl]metylene]amino]oxy]-2-metylpropionic acid (WHO)

Foreign Names

  • Aztreonamum (Latin)
  • Aztreonam (German)
  • Aztréonam (French)
  • Aztreonam (Spanish)

Generic Names

  • Aztreonam (OS: DCIT, USAN, BAN, JAN)
  • Aztréonam (OS: DCF)
  • BRN 3577211 (IS)
  • SQ 26776 (IS: Squibb)
  • UNII-G2B4VE5GH8 (IS)
  • Aztreonam (PH: JP XVI, USP 38)
  • Aztreonam Lysine (OS: USAN)
  • Corus1020 (IS)

Brand Names

  • Atreon
    Square, Bangladesh
  • Azactam
    Abeefe Bristol-Myers Squibb, Peru; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Ecuador; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, India; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Pakistan; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; E. R. Squibb & Sons, United Kingdom; Eisai, Japan; Eurofarma, Brazil; Glaxo Smithkline, Lebanon; GlaxoSmithKline, Egypt; P & D, Malta; Sanofi-Aventis, France
  • Aztram
    Shanxi C & Y, Philippines
  • Aztreo
    Zydus Cadila, India
  • Aztreonam
    Vitalis, Venezuela
  • Aztreonam Fresenius Kabi
    Fresenius Kabi, United States
  • Aztreonam Norgreen
    Norgreen, Argentina
  • Aztreonam Richet
    Richet, Argentina
  • Aztreonam Richet (Aztreonam and Arginine)
    Biotec Chile, Chile
  • Aztreonam Vitalis
    Vitalis, Guatemala; Vitalis, Nicaragua
  • Cayston
    Gilead, Australia; Gilead, Canada; Gilead, Germany; Gilead, Greece; Gilead, Israel; Gilead, Lithuania; Gilead, Poland; Gilead, Slovenia; Gilead, United States; Gilead Sciences, Italy
  • Primbactam
    Guidotti, Italy
  • Trezam
    Glenmark, India
  • Vebac
    Fahrenheit, Indonesia
  • Cayston
    Gilead, Belgium; Gilead, Switzerland; Gilead, Denmark; Gilead, Spain; Gilead, France; Gilead, Ireland; Gilead, Norway; Gilead, Sweden; Gilead Sciences, United Kingdom; Gilead Sciences International, Austria


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.